APA (7th ed.) Citation

I, S., IB, S., R, A., RB, D., YS, H., O, T., . . . L, Z. (2025). Response to "Considerations for integrating SGLT2 inhibitors into systemic lupus erythematosus management: Opportunities and challenges" by Chen et al. Seminars in arthritis and rheumatism, 75, 152868. https://doi.org/10.1016/j.semarthrit.2025.152868

Chicago Style (17th ed.) Citation

I, Sagy, et al. "Response to "Considerations for Integrating SGLT2 Inhibitors into Systemic Lupus Erythematosus Management: Opportunities and Challenges" by Chen Et Al." Seminars in Arthritis and Rheumatism 75 (2025): 152868. https://doi.org/10.1016/j.semarthrit.2025.152868.

MLA (9th ed.) Citation

I, Sagy, et al. "Response to "Considerations for Integrating SGLT2 Inhibitors into Systemic Lupus Erythematosus Management: Opportunities and Challenges" by Chen Et Al." Seminars in Arthritis and Rheumatism, vol. 75, 2025, p. 152868, https://doi.org/10.1016/j.semarthrit.2025.152868.